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An efficient nano-sized delivery system is presented here allowing the immobilized, picolinium-tethered
organic ligand to be released by X-ray irradiation. A marked difference was observed in the
fragmentation efficiency by using conventional Cs-137 vs. pulsed sources.Almost a decade ago we reported the rst fragmentation of
complex organic substrates by X-ray and gamma-ray irradiation
providing an opportunity to activate photolabile probes deep
within biological tissues where light cannot penetrate.1,2 In this
original experiment a tethered gadolinium(III) complex was
used as an electron source and also as a contrast agent, allowing
the bio-distribution of the probe to be followed in vivo.3,4 The
developed system shared common features with “caged
substrates” used in molecular biology, physiology and neuro-
sciences allowing the light-gated release of biologically active
compounds in high spatial integrity, where the activity of the
biomolecule is masked by the photosensitive group and the
photolysis restores the biological activity.3,4 We demonstrated
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70at 1.17 MeV (g-ray) the radiolysis produces clean and qualita-
tively similar fragmentation to near-UV photolysis.1 Although
the mechanism of the Gd(III)-sensitized radiolysis is not well
understood, our working hypothesis stands on the grounds of
converting high-energy photons to electrons by photoelectron
and/or Auger/Compton processes in the presence of a metal
atom, that converts photons to electrons more efficiently than
radiation generates electrons from water. According to this
putative mechanism, electrons are transferred in ne to the
photodevice, which undergoes ET (electron transfer)-mediated
chemical transformation/fragmentation. The role of the metal
[i.e. the Gd(III) in the presented model] was double, as it (i)
played the role of an efficient sensitizer and (ii) offered an
opportunity to follow the distribution of the device in the body
in real time under in vivo conditions by using conventional T1
weighted MR imaging modality.
Our preliminary studies established the proof of principle of
the selective fragmentation by exposure to X, or, g-rays, but also
showed areas in which improvements are needed to take the
approach further. It was observed by MRI that the intravenous
(iv) injected Gd-DOTAGA-sensitized devices were eliminated
rapidly from the blood stream and cleared to the bladder. The
serum residence time of the DOTAGA-sensitized device was in
order of minutes. That was essentially attributed to a rapid renal
clearance, known also for related DOTAGA analogs. Twenty-
four-hour urine samples showed that 60% to 70% of the iv-
injected device was excreted. The kinetic of this metabolism
was similar to that of the Gd-DOTAGA, and warranted for less
polar sensitizers for increased systemic circulation.
Here we report a development with a considerably improved
lypophilicity balance and sensitivity of the probe by using ultra
small superparamagnetic iron oxide (USPIO) nanoparticles
(NPs) as immobilization platforms, which are among the few
nanomaterials that are bio-compatible and approved forThis journal is © The Royal Society of Chemistry 2020
Scheme 2 Synthesis of the butyne hydroxylmethylene bisphospho-
nate (HMBP-yne) linker, 2.
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View Article Onlinetherapeutic use.5 USPIO NPs were used here (i) for the
immobilization/support of the redox probe; (ii) for tracking the
biodistribution of the probe by T2 weighted MRI and (iii) for the
generation of Auger/Compton electrons upon X or g-ray irradi-
ation (Scheme 1). In order to increase the ET sensitivity of the
probe, the original quinoline scaffold was replaced by our
recently developed hydroxyethyl picolinium sensor: the probe
undergoes selective fragmentation at E ¼ 1.14 V (vs. HNE),6
a value low enough for allowing efficient activation by Auger/
Compton electrons, while being lower than the limit of bio-
logical reducing systems that is approximately 0.65 V, thus
may not be activated in vivowithout external trigger.5Our earlier
observation was in agreement with the heterolytic (radical ionic)
rather than homolytic bond cleavage as the major ET frag-
mentation path.6
Classical non-aqueous sol–gel synthesis (the ‘benzyl alcohol
route’) was used for the preparation of USPIO NPs, opting for
microwave activation.7 This protocol allowed reducing consid-
erably the synthesis time (30 min, vs. 2 days in autoclave), and
also gave hand on the precise control of the size, resulting in
NPs with an average diameter of 9 nm, with high reproduc-
ibility.7 The prepared NPs were coated by bisphosphonate
anchoring groups. Bisphosphonates have remarkable capacity
to chelate divalent cations such as Ca2+, Mg2+ as well as Fe3+,
Fe2+ and the binding affinity can be increased by the presence of
an extra hydroxyl group (hydroxylmethylene bisphosphonate,
HMBP).8 The increased affinity is probably due to the tridentate
binding ability of the ligand to the cation. Noteworthy, the
HMBP family is orthogonal to a large variety of terminal func-
tions, a fact that was already exploited in a number of elegant
coating strategies.9
HMBP-yne ligand, 2, was prepared by using a straightfor-
ward 3 steps synthesis (Scheme 2).10 Accordingly, pent-4-ynoyl
acid chloride was reacted with tris(trimethylsilyl)phosphite
(neat) at 20 C, then the product was hydrolyzed in the pres-
ence of methanol leading to the desired 2, in 70% overall yield.
The surface functionalization was achieved by adding 2 to the
emulsion of USPIO NPs at pH 2. At this pH, the protonated, thus
positively charged NPs, adsorbed rapidly the negatively charged
bisphosphonates. NPs were then separated from theScheme 1 Cartoon of the activation of the USPIO NP immobilized
redox probe. Electrons generated by Auger/Compton process by X or
g-ray irradiation results in fragmentation of the covalently linked
ligand.
This journal is © The Royal Society of Chemistry 2020supernatant by precipitation followed by magnet-sorting and
were washed 3 times. The coated USPIO-yne NPs were re-
dispersed in water at pH 7.4, and the amount of the absorbed
ligand was quantied by thermogravimetric analysis (TGA) and
also, by energy dispersive X-ray analysis (EDX, Fig. SI2†). A value
of 440  40 HMBP-yne anchoring group was obtained based on
the iron/phosphorus atomic ratio per NPs. The iron concen-
tration was determined by colorimetric assay (ESI†).
4-Hydroxyethyl picolinium, 4, having pyrene butyrate uo-
rescent reporter was selected as redox fragmenting element
(Scheme 3).6 Pyrene was selected here being the most resistant
among all uorescent tags under redox and radiolytic condi-
tions. Probes were prepared from pyridine hydroxyethylene 3 in
a short esterication/quaternarisation sequence by using 2-
azidoethyl triuoromethanesulfonate as alkylating agent.
Picolinium probes were graed to the surface-linked
bisphosphonate (HMBP-yne) by click chemistry1,6 (Fig. 1a). It
was considered, that the polar quaternary picolinium salt may
ensure sufficient wetting to stabilize the colloid system in water,
thus no other hydrophilic ligands were added. The coupling
between HMBP-yne-coated iron oxide and picolinium probes
was realized by copper(I)-catalyzed azide/alkyne cycloaddition
(CuAAC), in the presence of a catalytic amount of CuI (0.1
equiv.) at rt for 24 h. As the solubility of the pyrene butyric acid-
functionalized 4 was very poor in water, the reaction was per-
formed in a mixture of acetonitrile/water (1/1). In the click
reaction the picolinium compound, 4, was used in sub-
stoichiometric amount (0.2 equiv.) in order to avoid satura-
tion and subsequent particles aggregation that may be driven by
inter-NPs strong p–p interaction between the pyrene ligands.
The obtained NPs (USPIO-0.2) were washed several times and
then re-dispersed in water (pH 7.4).
The hydrodynamic size of the nanoplatforms (USPIO-yne
and USPIO-0.2) d ¼ 17 nm (DLS), respectively, which
conrmed no aggregation, and also conrmed the colloidal
stability of the dispersion at physiological pH (ESI†).§Scheme 3 Synthesis of the picolinium redox probe, 4, having pyrene
butyrate fluorescent reporter.
RSC Adv., 2020, 10, 3366–3370 | 3367
Fig. 1 (a) Huisgen 1,3 cycloaddition of picolinium azide on USPIO-yne NPs and schematic representation of the pyrene butyric acid release upon
saponification, or, after redox fragmentation under X or g ray irradiation; (b) FTIR spectra of USPIO-yne NPs (green), USPIO-0.2 (orange) and of
picolinium azide (blue) (KBr). (For extended spectra of USPIO-yne NPs see Fig. SI4†).
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View Article OnlineNanoplatforms were characterized by FTIR (Fig. 1b). The
USPIO-yne NP spectrum (Fig. 1b, green curve and Fig. SI4†)
showed a characteristic broad band at 600 cm1, assigned to theFig. 2 T2 weighted MRI images and contrast variation showing the NP
biodistribution after injection in B6 mice. The graphs show the clear-
ance of the contrast signal (in arbitrary units) measured at 15 min,
45 min, 3 h 30 min, and 24 h after injection in the liver (blue), spleen
(red) and kidneys (green).
3368 | RSC Adv., 2020, 10, 3366–3370vibration of the iron–oxygen bond at the surface, and strong
stretching bands in the region of 1200 to 900 cm1 that were
assigned to P–O stretches of the HMBP-yne ligand.8 The FTIR
spectrum of the picolinium azide, 4, exhibited distinctive peaks
(Fig. 1b, blue curve), such as the azide stretching (2150 cm1),
ester bond stretching (1750 cm1), and pyrene aromatics
(845 cm1), respectively. The presence of the triate counter-ion
was conrmed by the presence of strong absorption bands at
1260 cm1 and at 1160 cm1 corresponding to the asymmetricTable 1 Fragmentation of the USPIO-immobilized redox probe
(USPIO-0.2) in water (pH 7.4) by irradiation at various doses (ID17
biomedical beamline of the ESRF synchrotron (Grenoble) and by using
conventional Cs-137 source (BIOBEAM 8000, INSERM U970, Paris)),
respectively. The fragmentation was followed by fluorescence (lex ¼
341 nm, lem ¼ 376 nm)
80 keV 0.6617 MeV
Dose (Gy) 0.3 3 30 0.3 3 30
Fragmentation (%) 25 62 82 6 19 27
This journal is © The Royal Society of Chemistry 2020
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View Article Onlinestretching of the SO3 and CF3 groups respectively, a strong band
at 1030 cm1 corresponding to symmetric (SO3) stretching
mode and a strong band at 638 cm1 attributed to the bending
vibration of the SO3 group.11
The presence of the redox probe on the NP was evidenced
by the characteristic IR signals of the functionalized NP
(USPIO-0.2 Fig. 1b, orange curve) with those of USPIO-yne and
azide 4. The disappearance of the 2100 cm1 band, charac-
teristic of the azide suggested the transformation of the azide
to triazole.‡ Noteworthy is the presence of the ester bond
stretching at 1750 cm1 as well as the pyrene aromatic peak at
845 cm1. It has to be noticed that the bands previously
assigned to the triate counter-ion disappeared, suggesting
their probable displacement during the washing procedure by
stronger anions (such as Cl during the pH adjustment by
using HCl (aq)). The optical properties of the various nano-
platforms were also characterized and compared (Fig. SI5†).
Noteworthy, the absorption peaks of the picolinium probe
were clearly distinguishable in the USPIO-0.2 spectrum
(Fig. SI5,† orange curve).
It was observed, that the picolinium group quenched effi-
ciently the uorescence of the pyrene in aqueous solution,
probably by Fo¨rster-type quenching/dark complex formation.
Moreover, the uorescence quenching was maintained aer
immobilisation on the NP surface: here the intra-, or inter-
molecular quenching and Fo¨rster-type energy transfer process
between the pyrene and the metal oxide NP may increase the
quenching efficiency of the assembled probe. The number of
the graed probes was quantied aer saponication of the
pyrene uorophore (NaOH, 1 N) for 24 h. The pH was re-
adjusted to neutral with HCl, and the uorescence of the
liberated pyrene butyric acid was quantied (Fig. SI6†). The
number of graed molecules was determined by comparing
the uorescence to a calibration curve; (lex ¼ 341 nm, lem ¼
376 nm), and an average number of 1.4 probe/NP was
obtained.
Since USPIO NPs are negative MRI contrast agents, we
used local changes in intensity on T2 weighted MRI to eval-
uate the USPIO-0.2 NP biodistribution in B6 mice using 7T-
MRI. Fig. 2 shows T2 weighted MRI images and the
dynamic contrast variation in liver, spleen, and kidneys
before injection and 15 min, 45 min, 3 h 30 min and 24 h aer
NP injection. Shortly aer injection (t ¼ 15 min) a large
negative contrast enhancement was observed in organs rich
in macrophages, such as in liver, kidneys and spleen. More-
over, the contrast in liver and spleen stays constant up to
45 min aer injection whereas intensity signal decreases
steadily in kidney. This fact suggests NP accumulation in the
liver and spleen and also NP clearance from the kidneys.
Hence, compared to our previous results obtained with
gadolinium(III) complex,1,3 the USPIO-0.2 NP residence time
in the body is greatly improved up to 24 h, notably in liver and
spleen.‡ The triazole characteristic peaks (IR) is usually displayed between 1650 and
1690 cm1: here are buried under other peaks.
This journal is © The Royal Society of Chemistry 2020The activation of the probes was validated in vitro at c¼ 5 mM
Fe concentrations§ by using either the ID17 biomedical beam-
line of the ESRF synchrotron (Grenoble) (conditions: cuvette:
quartz, d ¼ 1 mm, beam: 80 keV, bunch length: 48 ps, bunch
repetition rate 5.68 MHz, dose rate 1.82 Gy s1, dose up to 30
Gy), or, a conventional Cs-137 source (BIOBEAM 8000, Gamma-
Service Medical GmbH; activity 80.29 TBq  20%; dose rate:
5.86 Gy min1). The fragmentation was quantied by following
the appearing uorescence, and reported in Table 1.{ While
efficient fragmentation was observed under both conditions at
low doses (up to 30 Gy) pulsed sources of the ESRF appeared
considerably more efficient: 82% of the uorescence was
recovered aer 30 Gy irradiation contrasting 27% of uores-
cence under conventional conditions. Although the origin of the
difference between the efficiency of the two type of redox frag-
mentation is not well understood, eventually non-linear effects
between the use of continuous vs. pulsed sources may be at
work.Conclusions
Pyrene butyrate uorescent reporter-armed picolinium probes
were immobilized on spherical, homogeneous USPIO NPs. The
MRI contrast ability of the prepared probe was evaluated and
the biodistribution of the probe was followed in B6 mice by
using 7T-MRI modality. A large negative contrast enhancement
was observed in liver, kidneys and spleen, whereas T2 signal
decreased steadily in kidney. Activation of the probes was vali-
dated in vitro at c ¼ 5 mM Fe concentrations by using either the
ID17 biomedical beamline facility of the ESRF synchrotron
(Grenoble), or, by using conventional Cs-137 source. While
efficient fragmentation was observed under both conditions up
to 30 Gy, pulsed sources of the ESRF appeared considerably
more efficient: 82% of the uorescence was recovered by 30 Gy
irradiation contrasting 27% of uorescence by using conven-
tional conditions. Results indicate that the coated nanoplat-
form may be suitable for the use as MRI contrast agent and also
as a drug delivery platform, in particular for liver indications.
Further studies are underway.Conflicts of interest
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